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during and after CPB. The levels of iNOS and COX-2 were detected
during and after CPB but without any difference between groups.
Phosphorylation of p38 MAP and ERK1/2 MAP kinases and of IκB
was detected before, during and after CPB. Levels of phospho-p38
MAP kinase but not of ERK1/2 MAP kinase and IκB tended to be
lower in animals on hypothermia than in the others (P < 0.1).
Conclusion This study shows for the first time that cardiac surgery
induces the expression of TNF-α in the myocardium as soon as
30 min after institution of CPB, before aortic clamping. This is
associated with the activation of p38 MAP and ERK1/2 MAP
kinases and NF-κB pathway. The inhibition of TNF-α expression by
hypothermia is related to the inhibition of p38 MAP kinase.
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Introduction Urinary trypsin inhibitor (UTI) (MIRACLID®, Mochida
Corp., Tokyo, Japan), an elastase inhibitor extracted from human
urine, has been used to treat for patients with acute pancreatitis or
acute circulatory failure since more than 15 years ago in Japan.
Objective The current study was performed in order to evaluate
the efficacy of UTI for vascular endothelial disorders in critical
illness.
Materials and methods Thirteen severe patients, who had an
APACHE II score above 20 at transportation to our emegency
room, were elected and randomly assigned to either a treated
group or a control group. The number of patients in the treated
group was five and eight patients were in the untreated group.
Maximum dose of UTI (30,000 U/ml) were administrated to
patients in the treated group at the emergency room. After
admission in the ICU, the neutrophil elastase level, IL-6 level,
thrombomodulin (TM) level, protein C level and UTI level in plasma
were examined daily until the 7th day after hospitalization. Values
are expressed as mean ± SD. An unpaired Student’s t test was
used and P < 0.05 was considered statistically significant.
Results In the untreated group, the UTI level in plasma at the 7th
day after hospitalization was siginificantly higher than that in the
treated group (96.9 ± 44.4 vs 15.6 ± 6.5 U/ml, P < 0.05). Also, the
TM level was also significantly different between the untreated
group and the treated group (6.0 ± 2.4 vs 3.6 ± 1.4 FU/l, P < 0.05)
at the 7th day. Other examination values showed no significant
differences between the two groups during their clinical courses.
Conclusion The half-time of UTI is very short (about 40 min) and
the plasma level linear decreases until 3 hours after its
administration. The difference of UTI level on the 7th day was
considered as spontaneous UTI. And vascular endothelial
disorders were recognized in the higer UTI level group at the same
day, but this group was the untreated group. This study proposes it
i important for high-dose administration of UTI at a very acute
phase in critical illness to inhibit the vascular endothelial disorders.
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We investigated the effect of urinary trypsin inhibitor (UTI) on the
output of plasma mean neutrophil elastase (PMNE) and cytokine.
The participants of this study are 15 trauma patients with shock on
arrival at our insutitution. We divide them in two groups: one group
is administrated 300,000 U (intravenous) UTI, and the other is the
control group. At 0, 1, 3, 5, and 7 days after hospitalization of each
group, we measured the serum levels of IL-6, IL-8, UTI, PMNE,
thrombomodulin, protein C, and the SIRS score and SOFA score
as an index of severity.
The PMNE levels in the UTI-administered group were observed to
be significantly lower than those in the control group at 1 and
3 days after hospitalization.
These data suggest that. UTI can suppress vascular endothelial
cell disorders by inhibiting the production of PMNE and by direct
inhibition of PMNE.
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Background Exosomes are small vesicles (50–100 nm) released
from cells after activation. We have previously shown that
exosomes derived from platelets of septic patients induce
apoptosis of endothelial and vascular smooth muscle cells through
a redox-dependent pathway. Since reactive oxygen species may be
involved in myocardial dysfunction of sepsis, the aim of this study
was to investigate a possible role of exosomes in sepsis-induced
myocardial dysfunction.
Methods Exosomes were separated by filtration and
ultracentrifugation of plasma from 26 septic shock patients (SSP)
and from 10 healthy volunteers. After separation, exosomes were
infused at a 0.5-fold plasma concentration in Langendorff-perfused
hearts from 22 New Zealand rabbits. In other experiments,
12 isolated rat papillary muscles were exposed to a 0.5-fold
plasma concentration of exosomes from septic patients and
healthy controls.
